Patents by Inventor Andrew John Baxter

Andrew John Baxter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hemolysis detection device, system and method
    Patent number: 10670614
    Abstract: Aspects of the present invention are directed to devices, systems and methods that enable the quick and reliable detection of hemolysis in a sample such that a sample which exhibits an unacceptable level of hemolysis can be flagged or disregarded in an associated diagnostic test.
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: June 2, 2020
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Andrew John Baxter, Paul William Cotton
  • HEMOLYSIS DETECTION DEVICE, SYSTEM AND METHOD
    Publication number: 20190339293
    Abstract: Aspects of the present invention are directed to devices, systems and methods that enable the quick and reliable detection of hemolysis in a sample such that a sample which exhibits an unacceptable level of hemolysis can be flagged or disregarded in an associated diagnostic test.
    Type: Application
    Filed: July 17, 2019
    Publication date: November 7, 2019
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Andrew John Baxter, Paul William Cotton
  • Hemolysis detection device, system and method
    Patent number: 10386374
    Abstract: Aspects of the present invention are directed to devices, systems and methods that enable the quick and reliable detection of hemolysis in a sample such that a sample which exhibits an unacceptable level of hemolysis can be flagged or disregarded in an associated diagnostic test.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: August 20, 2019
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Andrew John Baxter, Paul William Cotton
  • HEMOLYSIS DETECTION DEVICE, SYSTEM AND METHOD
    Publication number: 20170248618
    Abstract: Aspects of the present invention are directed to devices, systems and methods that enable the quick and reliable detection of hemolysis in a sample such that a sample which exhibits an unacceptable level of hemolysis can be flagged or disregarded in an associated diagnostic test.
    Type: Application
    Filed: September 29, 2015
    Publication date: August 31, 2017
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Andrew John Baxter, Paul William Cotton
  • METHOD FOR APPROXIMATING REMAINING LIFETIME OF ACTIVE DEVICES
    Publication number: 20160116368
    Abstract: A method of calculating an effective age of an active optical cable including a fiber optic cable, at least one optical transducer, a first memory, and a second memory includes, during regular intervals that are divided into regular subintervals and after each of the regular subintervals, sensing an operational parameter of the active optical cable and recording in the second memory a value corresponding to a sensed operational parameter; after each of the regular intervals, storing in the first memory the values recorded in the second memory; and calculating the effective age of the active optical cable based on the values stored in the first memory.
    Type: Application
    Filed: October 23, 2015
    Publication date: April 28, 2016
    Inventors: Joshua R. CORNELIUS, Eric Jean ZBINDEN, Jean-Marc Andre VERDIELL, William J. KOZLOVSKY, Kevin BURT, Thomas Benjamin TROXELL, Lesly LEROY, David A. LANGSAM, Andrew John BAXTER
  • Vasopressin Vantagonists
    Patent number: 8202858
    Abstract: The present invention concerns compounds inter alia according to general formula 1a. Compounds according to the invention are vasopressin V1a receptor antagonists. Pharmaceutical compositions of the compounds are useful as treatment of dysmenorrhoea.
    Type: Grant
    Filed: August 24, 2005
    Date of Patent: June 19, 2012
    Assignee: Vantia Limited
    Inventors: Andrzej Roman Batt, Martin Lee Stockley, Michael Bryan Roe, Celine Marguerite Simone Heeney, Andrew John Baxter, Peter Hudson, Rachel Handy
  • VASOPRESSIN V1A ANTAGONISTS
    Publication number: 20120101082
    Abstract: The present invention concerns compounds inter alia according to general formula 1a. Compounds according to the invention are vasopressin V1a receptor antagonists. Pharmaceutical compositions of the compounds are useful as treatment of dysmenorrhoea.
    Type: Application
    Filed: December 19, 2011
    Publication date: April 26, 2012
    Inventors: ANDRZEJ ROMAN BATT, MARTIN LEE STOCKLEY, MICHAEL BRYAN ROE, CELINE Marguerite Simone HEENEY, ANDREW JOHN BAXTER, PETER HUDSON, RACHEL HANDY
  • Vasopressin V1a Antagonists
    Publication number: 20090029965
    Abstract: The present invention concerns compounds inter alia according to general formula 1a. Compounds according to the invention are vasopressin V1a receptor antagonists. Pharmaceutical compositions of the compounds are useful as treatment of dysmenorrhoea.
    Type: Application
    Filed: August 24, 2005
    Publication date: January 29, 2009
    Applicant: Ferring B.V.
    Inventors: Andrzej Roman Batt, Martin Lee Stockley, Michael Bryan Roe, Celine Marguerite Simone Heeney, Andrew John Baxter, Peter Hudson, Rachel Handy
  • Benzamide derivatives as oxytocin agonists and vasopressin antagonists
    Publication number: 20080275026
    Abstract: Novel compounds according to general formula 1, wherein G1 is NR5R6 or a fused polycyclic group that are specific OT receptor agonists and/or V1a receptor antagonists. Pharmaceutical compositions comprising such compounds are useful in the treatment of, inter alia, primary dysmenorrhoea.
    Type: Application
    Filed: June 20, 2008
    Publication date: November 6, 2008
    Inventors: Peter Hudson, Andrzej Roman Batt, Celine Marguerite Simone Heeney, Andrew John Baxter, Michael Bryan Roe, Peter Andrew Robson
  • Benzamide derivatives as oxytocin agonists and vasopressin antagonists
    Patent number: 7407949
    Abstract: Novel compounds according to general formula 1, wherein G1 is NR5R6 or a fused polycyclic group that are specific OT receptor agonists and/or V1a receptor antagonists. Pharmaceutical compositions comprising such compounds are useful in the treatment of, inter alia, primary dysmenorrhoea.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: August 5, 2008
    Assignee: Ferring B.V.
    Inventors: Peter Hudson, Andrzej Roman Batt, Celine Marguerite Simone Heeney, Andrew John Baxter, Michael Bryan Roe, Peter Andrew Robson